Furthermore, NORAD was introduced as a suppressor of autophagy that also inhibited apoptosis and assisted NB metastasis, proliferation and drug resistance [33]; hence, it can be argued that this lncRNA may be yet another suitable candidate to be utilised in NB as a biomarker of progression. This evidence concerns the gene NORAD and neuroblastoma.